What contract structures best protect hospitals against another Intravenous Solution Market supply shock?

Dual-source awards with named alternate manufacturing sites, allocation-priority clauses, and vendor-managed buffer inventory of 30 to 45 days. Single-award tenders on lowest price offer no protection [7]. Read More

How should procurement teams evaluate total cost when switching from PVC to polyolefin containers?

Model beyond unit price: include pump-set compatibility, storage footprint, disposal fees, and any revalidation of drug stability data. Conversion typically raises container cost 20–30% while reducing waste-handling and compliance costs [2]. Read More

Which competitive moves matter most for investors tracking the Intravenous Solution Market?

Watch vertical integration into film extrusion and compounder installations rather than headline capacity announcements. Both create switching costs that tender pricing cannot easily erode [12]. Read More

Do balanced crystalloids change supplier economics compared with normal saline?

Marginally. Balanced formulations carry modestly higher production complexity and price, but they shift mix within an existing category rather than expanding volume [17]. Read More

What integration challenges arise when adding smart-pump data to the Intravenous Solution Market supply chain?

Drug-library harmonisation across departments is the main obstacle, followed by HL7 interface maintenance. Health systems routinely underestimate the pharmacist hours required to govern libraries after go-live [9]. Read More

Are emerging-market local manufacturing partnerships worth the regulatory overhead?

Usually yes where tender rules grant local-content preference, as in India and Brazil. Payback depends on securing multi-year public volume commitments before committing capital [11]. Read More

What regulatory nuance most often surprises new entrants to the Intravenous Solution Market?

Extractables and leachables requirements differ meaningfully between jurisdictions, so a container qualified in one region may need full re-testing elsewhere. Budget 18–30 months per presentation [2]. Read More

Intravenous Solution Market (2026 - 2035)

Intravenous solution market Research Report Information By Nutrition Type (Peripheral Parenteral Nutrition and Total Parenteral Nutrition), By Bag Type (Large Volume Bags (>250 ml) and Small Volume Bags (<250 ml)), By Nutritional Content (Amino Acid Solution, Carbohydrates, Vitamins & Minerals, Parenteral Lipid Emulsion, and Others), By End User (Hospital & Clinics, Ambulatory Surgical Centers, and Home Care), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2026-2035

CAGR

5.43%

2025 Market Size

USD 14.48 Billion

2035 Market Size

USD 24.57 Billion

Healthcare ● Updated August 24, 2026 Report ID: MRFR/HC/0727-CR | Pages: 124 | Author: Nidhi Mandole, Rahul Gotadki

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Overview |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Market Summary & Key Report Takeaways |
1. 2.1 Takeaways by Type |
2. 2.2 Takeaways by Solution Composition & Packaging Material |
3. 2.3 Takeaways by End User & Geography
3 Global Market Size & Forecast (2021–2035) |
1. 3.1 Historical Market Size (2021–2024) |
2. 3.2 Base Year Assessment (2025) |
3. 3.3 Forecast Market Size (2026–2035) |
4. 3.4 Year-over-Year Growth Analysis
4 Market Dynamics — Driver Impact Analysis |
1. 4.1 Surgical Volume Recovery & Procedure Intensity |
2. 4.2 Supply-Chain Onshoring & Capacity Reshoring |
3. 4.3 Packaging Substitution as a Value Driver |
4. 4.4 Home Infusion & Care-Setting Migration
5 Market Dynamics — Restraints Impact Analysis |
1. 5.1 Price Compression in a Commoditised Category |
2. 5.2 Fluid Stewardship & Enteral-First Protocols |
3. 5.3 Conversion Capital & Validation Timelines
6 Market Opportunity Analysis |
1. 6.1 Automated Compounding & Closed-System Nutrition Platforms |
2. 6.2 Emerging-Market Local Manufacturing Partnerships |
3. 6.3 Premium Formulations for Oncology & Critical Care |
4. 6.4 Infusion Data Monetisation & Managed-Service Models |
5. 6.5 Resilience-as-a-Service Supply Contracts |
6. 6.6 Industry Value Chain Analysis |
7. 6.7 Porter's Five Forces Analysis
7 Regional Market Share & Country-Level Analysis |
1. 7.1 North America | |
  1. 7.1.1 US | |
  2. 7.1.2 Canada | |
  3. 7.1.3 Mexico |
2. 7.2 Europe | |
  1. 7.2.1 Germany | |
  2. 7.2.2 UK | |
  3. 7.2.3 France | |
  4. 7.2.4 Italy | |
  5. 7.2.5 Spain | |
  6. 7.2.6 Nordic Countries | |
  7. 7.2.7 Russia | |
  8. 7.2.8 Rest of Europe |
3. 7.3 Asia-Pacific | |
  1. 7.3.1 China | |
  2. 7.3.2 India | |
  3. 7.3.3 Japan | |
  4. 7.3.4 South Korea | |
  5. 7.3.5 ASEAN | |
  6. 7.3.6 Rest of Asia-Pacific |
4. 7.4 South America | |
  1. 7.4.1 Brazil | |
  2. 7.4.2 Argentina | |
  3. 7.4.3 Rest of South America |
5. 7.5 Middle East & Africa | |
  1. 7.5.1 Saudi Arabia | |
  2. 7.5.2 UAE | |
  3. 7.5.3 South Africa | |
  4. 7.5.4 Egypt | |
  5. 7.5.5 Rest of Middle East & Africa
8 Future Outlook (2026–2035) |
1. 8.1 Clinical Decision Support as Standard Infrastructure |
2. 8.2 Sustainability Reporting & Packaging Carbon Disclosure |
3. 8.3 Nutrition Personalisation & Automated Compounding |
4. 8.4 Preparedness Funding & Capacity Economics
9 Market Segmentation Analysis |
1. 9.1 By Type | |
  1. 9.1.1 Total Parenteral Nutrition (TPN) | |
  2. 9.1.2 Peripheral Parenteral Nutrition (PPN) |
2. 9.2 By Solution Composition | |
  1. 9.2.1 Saline Solutions | |
  2. 9.2.2 Carbohydrate (Dextrose) Solutions | |
  3. 9.2.3 Amino Acid Solutions | |
  4. 9.2.4 Lipid Emulsions | |
  5. 9.2.5 Vitamins & Trace Elements |
3. 9.3 By Packaging Material | |
  1. 9.3.1 Glass Bottles | |
  2. 9.3.2 PVC Plastic Bags | |
  3. 9.3.3 Non-PVC Polyolefin Bags | |
  4. 9.3.4 Other Formats |
4. 9.4 By End User | |
  1. 9.4.1 Hospitals & Clinics | |
  2. 9.4.2 Ambulatory Surgical Centres | |
  3. 9.4.3 Home-Care Settings | |
  4. 9.4.4 Long-Term Care & Others
10 Competitive Landscape |
1. 10.1 Market Concentration Analysis (2026) |
2. 10.2 Competitive Benchmarking Matrix |
3. 10.3 Company Profiles | |
  1. 10.3.1 Baxter International | |
  2. 10.3.2 Fresenius Kabi | |
  3. 10.3.3 B. Braun Melsungen | |
  4. 10.3.4 Otsuka Pharmaceutical Factory | |
  5. 10.3.5 ICU Medical | |
  6. 10.3.6 Sichuan Kelun Pharmaceutical | |
  7. 10.3.7 Terumo Corporation | |
  8. 10.3.8 Nipro Corporation | |
  9. 10.3.9 Grifols | |
  10. 10.3.10 Pfizer (Hospira) | |
  11. 10.3.11 Amanta Healthcare | |
  12. 10.3.12 JW Life Science
11 Recent News & Developments
12 Report Scope & Methodology |
1. 12.1 Study Period & Base Year |
2. 12.2 Data Sources & Estimation Framework |
3. 12.3 Abbreviations
13 Detailed Sources & Citations
14 Frequently Asked Questions
15 LIST OF TABLES |
TABLE 1 Global Intravenous Solution Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Intravenous Solution Market — Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Driver Impact Analysis Matrix, 2026–2035 |
TABLE 4 Restraint Impact Analysis Matrix, 2026–2035 |
TABLE 5 Global Market Size, by Region, 2021–2035 (USD Billion) |
TABLE 6 North America Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 7 Europe Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 8 Asia-Pacific Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 9 South America Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 10 Middle East & Africa Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 11 Global Market Size, by Type, 2021–2035 (USD Billion) |
TABLE 12 Global Market Size, by Solution Composition, 2021–2035 (USD Billion) |
TABLE 13 Global Market Size, by Packaging Material, 2021–2035 (USD Billion) |
TABLE 14 Global Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 15 North America Market Size, by Type & Solution Composition, 2021–2035 (USD Billion) |
TABLE 16 Europe Market Size, by Packaging Material & End User, 2021–2035 (USD Billion) |
TABLE 17 Asia-Pacific Market Size, by Type & End User, 2021–2035 (USD Billion) |
TABLE 18 South America Market Size, by Solution Composition, 2021–2035 (USD Billion) |
TABLE 19 Middle East & Africa Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 20 Competitive Benchmarking Matrix, 2026 |
TABLE 21 Company Profiles — Key Players |
TABLE 22 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 23 Report Scope & Methodology Summary |
TABLE 24 Detailed Sources & Citations Index
16 LIST OF FIGURES |
FIGURE 1 Market Dynamics — Drivers, Restraints & Opportunities Overview |
FIGURE 2 Industry Value Chain Analysis |
FIGURE 3 Porter's Five Forces Analysis |
FIGURE 4 Global Market Size Trend & Forecast (2021–2035) |
FIGURE 5 Year-over-Year Growth Curve (2022–2035) |
FIGURE 6 Market Share by Type, 2025 vs 2035 |
FIGURE 7 Market Share by Solution Composition, 2025 |
FIGURE 8 Market Share by Packaging Material, 2025 vs 2035 |
FIGURE 9 Market Share by End User, 2025 |
FIGURE 10 Regional Revenue Share Distribution, 2025 |
FIGURE 11 Regional CAGR Comparison, 2026–2035 |
FIGURE 12 Country-Level Growth Heat Map |
FIGURE 13 Competitive Landscape — Revenue Share Positioning, 2026 |
FIGURE 14 Strategic Positioning Matrix — Scale vs Specialisation |
FIGURE 15 Packaging Transition Timeline by Region

Certified Researchers

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
By Type	Total Parenteral Nutrition, Peripheral Parenteral Nutrition	Total Parenteral Nutrition	Peripheral Parenteral Nutrition
By Solution Composition	Saline Solutions, Carbohydrate (Dextrose) Solutions, Amino Acid Solutions, Lipid Emulsions, Vitamins & Trace Elements	Saline Solutions	Lipid Emulsions
By Packaging Material	Glass Bottles, PVC Plastic Bags, Non-PVC Polyolefin Bags, Other Formats	PVC Plastic Bags	Non-PVC Polyolefin Bags
By End User	Hospitals & Clinics, Ambulatory Surgical Centres, Home-Care Settings, Long-Term Care & Others	Hospitals & Clinics	Home-Care Settings
By Region	North America, Europe, Asia-Pacific, South America, Middle East & Africa	North America	Asia-Pacific

Market Segmentation Overview

By Type

Sub-Segment	Key Trend
Total Parenteral Nutrition	Multi-chamber standardised bags cede ground to automated individualised admixtures in tertiary centres.
Peripheral Parenteral Nutrition	Earlier nutritional intervention protocols widen eligibility in general wards and step-down units.

Type segmentation captures the clearest tension in the Intravenous Solution Market: revenue concentration in critical care against volume growth in shorter, lower-acuity courses. Suppliers holding both presentations under one clinical relationship convert ward patients into long-stay nutrition customers without competitive re-tendering.

By Solution Composition

Sub-Segment	Key Trend
Saline Solutions	Price-anchored commodity; balanced crystalloid substitution reshuffles mix without expanding volume
Carbohydrate (Dextrose) Solutions	Steady demand tied to caloric support and glycaemic management protocols
Amino Acid Solutions	Higher-concentration presentations reduce fluid load in restrictive-volume patients.
Lipid Emulsions	Fish-oil and olive-oil blends displace soybean-only formulations on hepatic safety evidence.
Vitamins & Trace Elements	Micronutrient shortages drive supply diversification and multi-source qualification.

Composition determines margin more decisively than any other dimension. Crystalloids fund the factory; nutrition components fund the research pipeline.

By Packaging Material

Sub-Segment	Key Trend
Glass Bottles	Retained for lipid and photolabile formulations despite weight and breakage penalties
PVC Plastic Bags	Declining share as phthalate justification requirements tighten in Europe and North America.
Non-PVC Polyolefin Bags	Fastest structural shift; multilayer film capacity becomes a competitive bottleneck.
Other Formats	Semi-rigid and specialty presentations serve niche compatibility requirements.

Packaging is where regulation translates directly into capital expenditure. Film extrusion capacity, not filling capacity, is the constraint that will decide which suppliers complete the transition on schedule.

By End User

Sub-Segment	Key Trend
Hospitals & Clinics	Consolidated tender purchasing with rising weight on supply-resilience guarantees
Ambulatory Surgical Centres	Lower per-case fluid spend but rapidly expanding procedure share.
Home-Care Settings	Specialty pharmacy channel economics reward patient-handling design and training support
Long-Term Care & Others	Ageing residential populations sustain baseline nutrition and hydration demand.

End-user mix increasingly determines route-to-market strategy. Tender expertise wins hospitals; pharmacy network partnerships win everything downstream of them.

By Region

Sub-Segment	Key Trend
North America	Redundancy contracting and reshored capacity reset supplier evaluation criteria
Europe	Phthalate restrictions and carbon disclosure make compliance a tender qualifier.
Asia-Pacific	Bed expansion and local-content incentives generate the largest absolute growth increment.
South America	Public auction reform and currency indexation shape contract structures
Middle East & Africa	Hospital construction outpaces local manufacturing, sustaining import dependence.

Geographic strategy in the Intravenous Solution Market now hinges on where a supplier can fill, not merely where it can sell. Freight economics and sovereignty policy both reward proximity.

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”

Guilherme Gomes Martins Product Management Director

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”